Growth Metrics

Health Catalyst (HCAT) Gains from Investment Securities (2018 - 2025)

Health Catalyst (HCAT) has disclosed Gains from Investment Securities for 8 consecutive years, with $6.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities rose 472.66% year-over-year to $6.1 million, compared with a TTM value of $4.5 million through Sep 2025, up 372.66%, and an annual FY2024 reading of -$1.6 million, changed N/A over the prior year.
  • Gains from Investment Securities was $6.1 million for Q3 2025 at Health Catalyst, up from -$1.6 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $6.1 million in Q3 2025 and bottomed at -$8.4 million in Q1 2022.
  • Average Gains from Investment Securities over 5 years is -$21222.2, with a median of $1.1 million recorded in 2022.
  • The sharpest move saw Gains from Investment Securities skyrocketed 700.56% in 2021, then tumbled 490.72% in 2022.
  • Year by year, Gains from Investment Securities stood at -$2.2 million in 2021, then surged by 222.22% to $2.6 million in 2022, then tumbled by 177.15% to -$2.0 million in 2023, then grew by 19.23% to -$1.6 million in 2024, then skyrocketed by 472.66% to $6.1 million in 2025.
  • Business Quant data shows Gains from Investment Securities for HCAT at $6.1 million in Q3 2025, -$1.6 million in Q3 2024, and -$2.0 million in Q3 2023.